Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Veteran's service-connected residuals of recurrent renal calculi are not rated higher than 30 percent since May 6, 2010. His asthma and allergic rhinitis do not warrant separate compensable evaluations.

The deciding factor: The medical evidence does not support a finding that the Veteran's kidney disorder required invasive or non-invasive procedures more than two times per year to manage his condition during the period in question, which is necessary for a 30 percent evaluation under DCs 7508 and 7509.

Claimed conditions
Recurrent renal calculi
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
April 16, 2012
Citation
1213831

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1213831.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.